BioHealth News Archive

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted…

Read More
Children’s National Event: Navigating from Research to Market Approval: The AGAMREE Journey

Children’s National Event: Navigating from Research to Market Approval: The AGAMREE Journey

Join Children’s National Hospital for a pivotal symposium on the journey of AGAMREE® from academic research to market approval for DMD treatment in children.…

Read More
BISNOW: In Nation’s Tightest Life Sciences Market, There Is Little Appetite To Build More Space

BISNOW: In Nation’s Tightest Life Sciences Market, There Is Little Appetite To Build More Space

February 1, 2024 Emily Wishingrad - The life sciences real estate train, which just a few years ago was reaching top speeds, is now pressing down firmly on the brakes.  …

Read More
Baltimore Banner: One biotech company is leaving, one is staying. What does that say about Baltimore?

Baltimore Banner: One biotech company is leaving, one is staying. What does that say about Baltimore?

Meredith Cohn - 2/6/2024 - Thrive Earlier Detection Corp., a startup company based on early cancer testing technology developed at the Johns Hopkins University, was snatched up…

Read More
WBJ: AstraZeneca doubles down on Montgomery County with $300M investment

WBJ: AstraZeneca doubles down on Montgomery County with $300M investment

By Sara Gilgore – Staff Reporter, Washington Business Journal - AstraZeneca PLC (NYSE: AZN) is leaving no doubt about its commitment to Montgomery County, pouring $300 million…

Read More
GEN: Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B

GEN: Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B

By Alex Philippidis -February 5, 2024 - Novo Holdings, the asset manager of the foundation that controls Novo Nordisk, has agreed to acquire contract development…

Read More
J.P. Morgan Releases 2024 Innovation Economy Outlook: What’s Next for Venture Capital?

J.P. Morgan Releases 2024 Innovation Economy Outlook: What’s Next for Venture Capital?

J.P. Morgan has released its 2024 Innovation Economy Outlook, offering valuable insights for those interested in the future of venture capital, investment trends, and…

Read More
BioHealth Innovation, Inc. (BHI) Welcomes Yaminah Leggett-Wells, Senior Director, Alliance Management at Amgen as Newest Member of the Board of Directors

BioHealth Innovation, Inc. (BHI) Welcomes Yaminah Leggett-Wells, Senior Director, Alliance Management at Amgen as Newest Member of the Board of Directors

ROCKVILLE, MARYLAND, February 5, 2024 – BioHealth Innovation, Inc. (BHI), a leading public-private nonprofit organization dedicated to advancing healthcare innovation in the BioHealth Capital…

Read More
Bio: House passes bill restoring full R&D expensing

Bio: House passes bill restoring full R&D expensing

On January 31, the House passed legislation to restore the immediate expensing of R&D expenses. The Biotechnology Innovation Organization (BIO) has long advocated for…

Read More
Maxim Biomedical, Inc. Secures Second NIH RADx Tech High Performance Award for Continued Development of At-Home FiarFly™ Reader and COVID-19 & Flu A/B Rapid Test

Maxim Biomedical, Inc. Secures Second NIH RADx Tech High Performance Award for Continued Development of At-Home FiarFly™ Reader and COVID-19 & Flu A/B Rapid Test

ROCKVILLE, Md., Feb. 1, 2024 /PRNewswire/ -- MaximBio, a leading innovator in next-generation healthcare diagnostic technologies, is pleased to announce that it has been granted a…

Read More
U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials

U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials

Global study will assess the safety and efficacy of the company's lead spinal fusion product, OsteoAdapt SP FREDERICK, Md., Feb. 1, 2024 /PRNewswire/ -- Theradaptive, the market…

Read More
BioBuzz: Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative

BioBuzz: Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative

By Jelena Ivanjac | January 30, 2024 - The end of 2023 marked the completion of Virginia’s first statewide life sciences initiative, Virginia Bio-Connect, which started in April…

Read More
Baltimore’s LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China

Baltimore’s LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China

BALTIMORE, Jan. 31, 2024 /PRNewswire/ -- LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced it has entered…

Read More
GEN: Top 10 Biopharma Takeover Targets of 2024

GEN: Top 10 Biopharma Takeover Targets of 2024

By Alex Philippidis - February 1, 2024 -  Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers…

Read More
Deadline Approaching: Apply to Be Part of the Maryland Delegation at BIO 2024

Deadline Approaching: Apply to Be Part of the Maryland Delegation at BIO 2024

The Maryland Department of Commerce invites companies to seize the opportunity to join the Maryland delegation at the BIO International Convention in San Diego,…

Read More